Design of Biodegradable Hydrogel for the Local and Sustained Delivery of Angiogenic Plasmid DNA
- 474 Downloads
To attain the effective local and sustained delivery of plasmid DNA (pDNA) encoding for a growth factor.
We hypothesized that controlling the degradation rate of biomaterials encapsulating pDNA via concurrent physical dissociation of the cross-linked structure and hydrolytic chain breakage of polymers would allow one to significantly broaden the range of pDNA release rate. This hypothesis was examined using ionically cross-linked polysaccharide hydrogels which were previously designed to rapidly degrade via engineering of ionic cross-linking junction and partial oxidation of polysaccharide chains.
The hydrogel degradation rates were varied over the broad range, and pDNA release correlated with the gel degradation rate. Degradable hydrogels were used for the local and sustained delivery of a pDNA encoding for vascular endothelial growth factor (VEGF) in the ischemic hindlimbs of mice, and local pDNA release significantly improved the recovery of blood perfusion as compared with a bolus injection of VEGFencoding pDNA.
This strategy to control the hydrogel degradation rate may be useful in regulating the delivery of a broad array of macromolecular drugs, and subsequently improve their therapeutic efficacy.
Key wordsblood perfusion degradation gene expression therapeutic angiogenesis
The authors thank the NIH (RO1 DE013033 and RO1 HL069957) for the financial support of this research. The authors also thank Mr. Francis Rauh of FMC Corporation for supplying the alginate samples.
- 4.A. A. Kocher, M. D. Schuster, M. J. Szabolcs, S. Takuma, D. Burkhoff, J. Wang, S. Homma, N. M. Edwards, and S. Itescu. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7:430–436 (2001).PubMedCrossRefGoogle Scholar
- 7.F. J. Giordano, P. P. Ping, M. D. McKirnan, S. Nozaki, A. N. DeMaria, W. H. Dillmann, O. MathieuCostello, and H. K. Hammond. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat. Med. 2:534–539 (1996).PubMedCrossRefGoogle Scholar
- 8.Y. Tsurumi, S. Takeshita, D. F. Chen, M. Kearney, S. T. Rossow, J. Passeri, J. R. Horowitz, J. F. Symes, and J. M. Isner. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 94:3281–3290 (1996).PubMedGoogle Scholar
- 10.X. J. Hao, A. Mansson-Broberg, P. Blomberg, G. Dellgren, A. J. Siddiqui, K. H. Grinnemo, E. Wardell, and C. Sylven. Angiogenic and cardiac functional effects of dual gene transfer of VEGF-A(165) and PDGF-BB after myocardial infarction. Biochem. Biophys. Res. Commun. 322:292–296 (2004).PubMedCrossRefGoogle Scholar
- 11.A. J. Comerota, R. C. Throm, K. A. Miller, T. Henry, N. Chronos, J. Laird, R. Sequeira, C. K. Kent, M. Bacchetta, C. Goldman, J. P. Salenius, F. A. Schmieder, and R. Pilsudski. Naked plasmid DNA encoding fibroblast growth factor type I for the treatment of end-stage unreconstructible lower extremity ischemia: Preliminary results of a phase I trial. J. Vasc. Surg. 35:930–936 (2002).PubMedCrossRefGoogle Scholar
- 19.D. H. Walter, M. Cejna, L. Diaz-Sandoval, S. Willis, L. Kirkwood, P. W. Stratford, A. B. Tietz, R. Kirchmair, M. Silver, C. Curry, A. Wecker, Y. S. Yoon, R. Heidenreich, A. Hanley, M. Kearney, F. O. Tio, P. Kuenzler, J. M. Isner, and D. W. Losordo. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents—An alternative strategy for inhibition of restenosis. Circulation 110:36–45 (2004).PubMedCrossRefGoogle Scholar